W2S-24837-46709
3 vaccinations
3 coded responses
29 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-19
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-21
- 2020-12-22
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2021-01-04
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-01-12
- 2021-01-14
- 2021-01-18
- 2021-01-23
- 2021-01-30
- 2021-02-06
-
2021-02-13
Survey response — day 35, dose 2MedDRA: Headache, Migraine — Feeling: FairFree text: Migraine headache but also went up to 11000 feet altitude concomitantlyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-20
- 2021-04-10
- 2021-07-12
-
2021-09-22
Dose 3 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
-
2021-12-22
Survey response — 3 months, dose 3MedDRA: Cough, Fatigue, Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend schoolFree text: Headache, sore throat, cough, congestion, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-03-23
Survey response — 6 months, dose 3MedDRA: COVID-19, Cough, Pre-existing disease, Viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Confirmed Covid 19 on 12/30/22, with chronic cough since then and additional virus infection Feb 2022 that has left lingering symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-23
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-24
- 2022-09-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-23 | Unsuccessful |
Free text
Release 4 — day 35, dose 2
Symptoms: Migraine headache but also went up to 11000 feet altitude concomitantly
Release 10 — 3 months, dose 3
Symptoms: Headache, sore throat, cough, congestion, fatigue
Release 11 — 6 months, dose 3
Symptoms: Confirmed Covid 19 on 12/30/22, with chronic cough since then and additional virus infection Feb 2022 that has left lingering symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ○ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release